• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nutriband Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    2/3/26 1:44:34 PM ET
    $NTRB
    Industrial Specialties
    Health Care
    Get the next $NTRB alert in real time by email
    false 0001676047 0001676047 2026-01-24 2026-01-24 0001676047 us-gaap:CommonStockMember 2026-01-24 2026-01-24 0001676047 NTRB:WarrantsMember 2026-01-24 2026-01-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of

    the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) January 24, 2026

     

    Nutriband, Inc.

     

    Nevada   000-40854   81-1118176
    (State or Other Jurisdiction
    of Incorporation)
      (Commission File Number)   (I.R.S. Employer
    Identification No.)

     

    121 S. Orange Ave. Suite 1500

    Orlando, Florida

      32801
    (Address of Principal Executive Offices)   (Zip Code)

     

    (407) 377-6695

    Registrant’s Telephone Number, Including Area Code

     

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock   NTRB   The Nasdaq Stock Market LLC
    Warrants   NTRBW   The Nasdaq Stock Market LLC

     

     

     

     

     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    The Company’s 2026Annual Meeting of Stockholders was held on January 24, 2026, in Orlando, Florida. At the meeting five proposals were on the agenda for approval by the Company’s stockholders: election of seven directors, ratification of the engagement of Sadler, Gibb & Associates, LLC as the Company’s independent audit firm for fiscal 2025 and approval of the Company’s Amendment to its Articles of Incorporation to increase the number of shares of the Company’s Preferred Stock authorized for issuance from 10,000,000 shares to 2o0,000 shares. In addition, the non-binding “say on pay” vote on approval of executive compensation and the “say on frequency” vote on the frequency of the say on pay vote were voted on by the stockholders. The results of the stockholder votes on each of these proposals is set forth below.

     

    At the 2025 Annual Meeting, the stockholders elected the seven candidates nominated by the Company’s Board of Directors to serve as directors for one-year terms, each until his or her successor is duly elected and qualified.

     

    The table below presents the results of the shareholder votes at the Company’s 2025 Annual Meeting on the election of seven directors, the ratification of the selection of the Company’s audit firm for 2024, the Company’s Amendment to its Articles of Incorporation to increase the number of shares of Preferred Stock authorized for issuance from 10,000,000 shares to 20,000,000 shares, and the votes on “say on pay” on executive compensation and “say on frequency” of the shareholder say on pay votes.:

     

    Following the completion of the shareholder meeting, the Board of Directors, at its Annual Meeting, elected the following two new directors to the Company’s Board of Directors, to serve and hold office until the next annual meeting of stockholders, or until their earlier resignacingn or removal from office.

     

    Alessandro Puddu, age 42, is an Italian Chartered Accountant and Statutory Auditor with a practice of audit, corporate advisory and financial reporting for industrial groups and listed companies. He advises companies on tax and corporate matters, company valuations, extraordinary corporate transactions and IAS/IFRS reporting, including consolidated financial statements. At the beginning of his career, he worked at PricewaterhouseCoopers as a Senior Auditor, reviewing Italian and multinational companies operating in various industrial sectors and is.enrolled in the Italian Register of Chartered Accountants (Dottori Commercialisti), the Register of Statutory Auditors held by the Italian Ministry of Economy and Finance, and the Register of Crisis & Insolvency Practitioners, and he has a Master’s Degree in Economics and Management.

     

    Viorica Carlig, age 50, has been the manager of TII Jet Services LDA, an aircraft service company, and has professional management experience for a substantial period in the management and growth of companies in the aircraft industry and as well in the industry’s regulatory compliance requirements. She received Ph.D. in Economics in 1999, and a Masters Degree in Business Administration from the Bucharest Academy of Economic Studies in 2006 and 1999, respectively. She further received Bachelor Degrees in Law and Commerce from the University of Bucharest and the Bucharest Academy of Economic Studies, in 2002 and 1998, respectively.

     

    1

     

     

    Nutriband Shareholder Meeting - 01/24/26  Total Votes   10,740,961    88.22%  % of
    Total
    Shares

     

    Director Nominations - #1 through
    #7
      Name  Votes
    For
       Votes
    Abstain
       Non-Vote   % of
    Total Shares
    For
     
    1  Gareth Sheridan   10,708,499    32,462    1,433,922    87.96%
    2  Serguei Melnik   10,718,645    22,316    1,433,922    88.04%
    3  Mark Hamilton   10,522,345    218,616    1,433,922    86.43%
    4  Radu Bujoreanu   10,538,426    202,535    1,433,922    86.56%
    5  Irina Gram   10,694,869    46,092    1,433,922    87.84%
    6  Stefani Mancas   10,536,442    204,519    1,433,922    86.54%
    7  Sergei Glinka   10,704,114    36,847    1,433,922    87.92%

     

       Votes
    For
       Votes
    Against
       Votes
    Abstain
       Non Vote   % of
    Total Shares
    For
     
    #2 - Ratify the selection of Sadler Gibb & Associates as Nutriband’s independent auditor for 2025   10,663,780    75,686    1,495    1,433,922    87.59%
    #3 - Adopt and aprove the Company’s Amendment to its Articles of Incorporation that would increase the number of authorized preferred shares from 10,000,000 to 20,000,000   10,500,777    239,819    365    1,433,922    86.25%
    #4 - Advisory aproval of executiver compensation   10,686,835    48,560    5,566    1,433,922    87.78%

     

       Every
    1 Year
       Every
    2 Years
       Every
    3 Years
       Votes
    Abstain
       Non Vote   % of
    Total Shares
    For
     
    #5 -Advisory vote on the frequency of the advisory vote on executive compensation   10,612,109    4,038    36,234    88,580    1,433,922    87.16%

     

    Item 9.01 Financial Statements and Exhibits

     

    (d) Exhibits

     

    The following exhibits are being filed with this Current Report on Form 8-K:

     

    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    2

     

     

    SIGNATURES

     

    PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

     

      NUTRIBAND, INC.
         
    Date: February 3, 2026 By: /s/ Gareth Sheridan
        Gareth Sheridan
        Chief Executive Officer

     

    3

     

    Get the next $NTRB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTRB

    DatePrice TargetRatingAnalyst
    1/22/2025$13.00Outperform
    Noble Capital Markets
    More analyst ratings

    $NTRB
    SEC Filings

    View All

    Nutriband Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - NutriBand Inc. (0001676047) (Filer)

    2/3/26 1:44:34 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - NutriBand Inc. (0001676047) (Filer)

    12/30/25 4:28:50 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form DEF 14A filed by Nutriband Inc.

    DEF 14A - NutriBand Inc. (0001676047) (Filer)

    12/19/25 11:01:52 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $NTRB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $NTRB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Noble Capital Markets initiated coverage on Nutriband with a new price target

    Noble Capital Markets initiated coverage of Nutriband with a rating of Outperform and set a new price target of $13.00

    1/22/25 9:24:55 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form 5 filed by Sheridan Gareth

    5 - NutriBand Inc. (0001676047) (Issuer)

    11/25/25 5:12:40 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    Goodman Gerald exercised 60,085 in-the-money shares at a strike of $1.93, increasing direct ownership by 1,001% to 66,085 units (SEC Form 5)

    5 - NutriBand Inc. (0001676047) (Issuer)

    10/21/25 1:50:53 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Chief Financial Officer Goodman Gerald

    4 - NutriBand Inc. (0001676047) (Issuer)

    12/2/24 3:49:25 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

    ORLANDO, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) has provided an update to shareholders on the key milestones and discussions from this years Annual Shareholders Meeting, held on Jan 24, 2026 in Orlando, Florida. Details and highlights may be found below. Addition of Two New Directors Allesandro PudduAlessandro Puddu is an Italian Chartered Accountant and Statutory Auditor with over 10 years of experience in audit, corporate advisory and financial reporting for industrial groups and listed companies. He advises companies on tax and corporate matters, company valuations, extraordinary corporate transactions and IAS/IFRS reporting, including con

    1/30/26 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband CEO Publishes Letter to Shareholders

    ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 and the potential outlook for 2026. The full text of the letter is below. Dear Shareholders, As we wrapped up a successful 2025, the entire team at Nutriband would like to extend our warmest appreciation to all of you for your continued support throughout 2025 and into 2026. I always stress and extend our appreciation to the many of you that have been with us from the beginning and now the many more who have joined our common goal along the way. This goal

    12/31/25 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

    Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe Nutriband Inc. Shareholders will retain 10% of the shareholding in Earth Vision Bio following the acquisition The expected closing date for the transaction is Dec 31, 2025. ORLANDO, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), today announced that it has signed an agreement to sell a 90% interest in its subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio. Earthvision Bio has developed and are commercializing a new category of sustainable p

    12/29/25 9:00:00 AM ET
    $INTC
    $NTRB
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    $NTRB
    Financials

    Live finance-specific insights

    View All

    Nutriband CEO Publishes Letter to Shareholders

    ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 and the potential outlook for 2026. The full text of the letter is below. Dear Shareholders, As we wrapped up a successful 2025, the entire team at Nutriband would like to extend our warmest appreciation to all of you for your continued support throughout 2025 and into 2026. I always stress and extend our appreciation to the many of you that have been with us from the beginning and now the many more who have joined our common goal along the way. This goal

    12/31/25 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

    ORLANDO, Fla., July 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") is today reminding shareholders of the key dates associated with its upcoming 25% Preferred stock dividend. Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August. 5th. Each preferred share will be convertible to one share of common stock following FDA approval of the Company's AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an ann

    7/18/25 9:15:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

    ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") announced today that its Board of Directors has approved and declared a 25% preferred stock dividend. Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August 5th. Each preferred share will be convertible to one share of common stock following FDA approval of the Company's AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an annual bas

    7/2/25 8:05:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Leadership Updates

    Live Leadership Updates

    View All

    Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

    ORLANDO, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (the "Company") is pleased to announce that it has been invited to present on the Emerging Growth Conference on August 20, 2025. The next Emerging Growth Conference is presenting on August 20, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chairman, Serguei Melnik in real time. Mr. Melnik will perform a presentation and may subsequently open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event and Mr. Melnik will do his best to

    8/18/25 9:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

    The Glinka family invested $4.5 million into Nutriband through the Company's April 2024 private placementORLANDO, FL / ACCESSWIRE / May 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, today announced the appointment of Sergei Glinka to its board of directors. Glinka is a seasoned and highly respected business executive with an impressive track record in leadership roles across major European companies.Mr. Glinka, an Estonian citizen, is an experienced and highly regarded businessman who has held numerous Executive and Board positions in large European Companies providing Glinka with deep insights and networks across various industri

    5/16/24 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nutriband Inc.

    SC 13D/A - NutriBand Inc. (0001676047) (Subject)

    9/19/24 11:38:15 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Nutriband Inc.

    SC 13G - NutriBand Inc. (0001676047) (Subject)

    2/13/24 8:33:52 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Nutriband Inc.

    SC 13G - NutriBand Inc. (0001676047) (Subject)

    2/12/24 3:57:44 PM ET
    $NTRB
    Industrial Specialties
    Health Care